HFNC and NCPAP in Extremely Preterm Infants
Extreme Prematurity

About this trial
This is an interventional basic science trial for Extreme Prematurity focused on measuring NCPAP, HFNC, Preterm infants, Cardiorespiratory behaviour, Non-invasive respiratory support
Eligibility Criteria
Inclusion Criteria:
- Infants with birth weight ≤ 1250 grams
- Infants that have been mechanically ventilated and undergoing their first elective extubation attempt
Exclusion Criteria:
- Major congenital anomalies, neuromuscular disease, hemodynamic instability (use of vasopressors or hypotension).
- Infants reintubated before initiation or during data collection.
- Parental/legal guardian consent not obtained.
Sites / Locations
- Montreal Children's Hospital
- Royal Victoria Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
HFNC/NCPAP
NCPAP/HFNC
HFNC will be provided for 45 minutes followed by NCPAP for 45 minutes. Cardiorespiratory signals including electrocardiogram (ECG), respiratory inductive plethysmography (RIP), oxygen saturation (SpO2) and Pulse rate will be recorded continuously during the interventions and analyzed offline.
NCPAP will be provided for 45 minutes followed by HFNC for 45 minutes. Cardiorespiratory signals including electrocardiogram (ECG), respiratory inductive plethysmography (RIP), oxygen saturation (SpO2) and Pulse rate will be recorded continuously during the interventions and analyzed offline.